The small molecule UCN3866 was confirmed as a potent antagonist of the methyl-tag readers such as polycomb CBX and CDY families of CHDs, and can inhibit PC3 prostate cancer cell proliferation through down-regulating transcription of the INK4a/ARE locus [183]. The gene discussed is CDKN2A; the disease is prostate cancer.